2 results
Approved WMORecruiting
Primary: To compare the efficacy of ruxolitinib versus Investigator*s choice Best Available Therapy (BAT) in patients with moderate or severe SR-cGvHD assessed by Overall Response Rate (ORR) at the Cycle 7 Day 1 visit.Secondary: To compare the rate…
Approved WMORecruiting
1. To investigate the impact of various resistance-type exercise variables (i.e. load, repetitions, volume) on skeletal muscle mass, strength and physical performance outcomes in (mal)nourished frail community-dwelling older adults.2. To investigate…